Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ICLR – ICON Public Limited Company

ICON plc
ICLR
$139.11
Name : ICON plc
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $11,054,279,680.00
EPSttm : 9.18
finviz dynamic chart for ICLR
ICON plc
$139.11
3.18%
$4.29

Float Short %

1.9

Margin Of Safety %

25

Put/Call OI Ratio

0.51

EPS Next Q Diff

0.31

EPS Last/This Y

3.71

EPS This/Next Y

1.05

Price

138.96

Target Price

178

Analyst Recom

1.67

Performance Q

-25.43

Relative Volume

0.66

Beta

1.15

Ticker: ICLR




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-08ICLR138.530.691.063454
2025-05-09ICLR133.880.701.463463
2025-05-12ICLR140.180.690.983467
2025-05-13ICLR139.890.750.074532
2025-05-14ICLR132.240.781.155536
2025-05-15ICLR130.570.729.693686
2025-05-16ICLR131.60.540.063319
2025-05-19ICLR131.310.691.152078
2025-05-20ICLR132.050.700.022217
2025-05-21ICLR126.850.480.382815
2025-05-22ICLR126.960.480.303115
2025-05-23ICLR127.490.470.333261
2025-05-27ICLR131.570.480.243280
2025-05-28ICLR130.790.510.033292
2025-05-29ICLR130.940.510.583299
2025-05-30ICLR130.220.520.133346
2025-06-02ICLR128.960.521.193359
2025-06-03ICLR133.740.530.283368
2025-06-04ICLR139.70.530.343268
2025-06-05ICLR134.950.510.863318
2025-06-06ICLR139.110.510.263310
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-08ICLR138.62-13.9257.313.34
2025-05-09ICLR133.96-13.9226.513.34
2025-05-12ICLR140.22-13.9305.413.34
2025-05-13ICLR140.49-13.9260.913.34
2025-05-14ICLR132.21-13.9200.113.34
2025-05-15ICLR130.63-13.9247.013.34
2025-05-16ICLR131.64-13.9266.513.34
2025-05-19ICLR130.75-14.0252.313.34
2025-05-20ICLR132.08-14.0268.913.34
2025-05-21ICLR126.70-14.0218.813.34
2025-05-22ICLR127.03-14.0262.113.34
2025-05-23ICLR128.07-14.0267.313.33
2025-05-27ICLR131.38-14.0284.813.29
2025-05-28ICLR130.81-14.0254.713.29
2025-05-29ICLR130.99-14.0260.113.29
2025-05-30ICLR130.28-14.0253.013.29
2025-06-02ICLR128.93-14.0248.813.29
2025-06-03ICLR133.76-14.0295.813.29
2025-06-04ICLR139.66-14.0302.513.29
2025-06-05ICLR134.82-14.0224.813.29
2025-06-06ICLR138.96-13.9289.313.31
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-08ICLR0.00-3.692.38
2025-05-09ICLR0.00-3.692.38
2025-05-12ICLR0.00-3.501.52
2025-05-13ICLR0.00-3.501.52
2025-05-14ICLR0.00-3.501.52
2025-05-15ICLR0.00-3.501.52
2025-05-16ICLR0.00-3.501.52
2025-05-19ICLR0.000.141.52
2025-05-20ICLR0.000.141.52
2025-05-21ICLR0.000.141.52
2025-05-22ICLR0.000.141.52
2025-05-23ICLR0.000.141.52
2025-05-27ICLR0.00-1.171.52
2025-05-28ICLR0.00-1.171.90
2025-05-29ICLR0.00-1.171.90
2025-05-30ICLR0.00-1.171.90
2025-06-02ICLR0.00-1.161.90
2025-06-03ICLR0.00-1.161.90
2025-06-04ICLR0.00-1.161.90
2025-06-05ICLR0.00-1.161.90
2025-06-06ICLR0.00-1.161.90
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

3.07

Avg. EPS Est. Current Quarter

3.23

Avg. EPS Est. Next Quarter

3.38

Insider Transactions

Institutional Transactions

-1.16

Beta

1.15

Average Sales Estimate Current Quarter

1976

Average Sales Estimate Next Quarter

1972

Fair Value

174.37

Quality Score

77

Growth Score

88

Sentiment Score

40

Actual DrawDown %

60

Max Drawdown 5-Year %

-63.4

Target Price

178

P/E

15.14

Forward P/E

9.69

PEG

3.76

P/S

1.37

P/B

1.16

P/Free Cash Flow

10.78

EPS

9.19

Average EPS Est. Cur. Y​

13.31

EPS Next Y. (Est.)

14.36

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.25

Relative Volume

0.66

Return on Equity vs Sector %

-16.1

Return on Equity vs Industry %

-2.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.33

EBIT Estimation

289.3
ICON plc
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 41250
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
stock quote shares ICLR – ICON Public Limited Company Stock Price stock today
news today ICLR – ICON Public Limited Company stock forecast ,stock prediction 2023 2024 2025
marketwatch ICLR – ICON Public Limited Company yahoo finance google finance
stock history ICLR – ICON Public Limited Company invest stock market
stock prices ICLR premarket after hours
ticker ICLR fair value insiders trading